欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/0880/001
药品名称Biseltoc 2.13 mg/ml
活性成分
    • PENTOXYVERINE CITRATE 2.13 mg/ml
剂型Oral solution
上市许可持有人Opella Healthcare France S.A.S. 82 Avenue Raspail Gentilly 94250 France
参考成员国 - 产品名称Finland (FI)
Biseltoc 2,13 mg/ml oraaliliuos
互认成员国 - 产品名称
    • Bulgaria (BG)
    • Romania (RO)
    • Austria (AT)
    • Italy (IT)
    • Belgium (BE)
    • Portugal (PT)
    • Spain (ES)
    • Luxembourg (LU)
    • Sweden (SE)
    • Norway (NO)
许可日期2016/04/20
最近更新日期2024/04/22
药物ATC编码
    • R05DB05 pentoxyverine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase